CEO & Co-Founder, Inmode
Search every verified Moshe Mizrahy interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Moshe Mizrahy, CEO and co-founder of InMode, stated during the company's first quarter 2025 earnings call that the medical aesthetic market continues to face headwinds from macroeconomic uncertainty and soft consumer demand. He said that based on the first quarter and the start of the second quarter, the company does not "see the light at the end of the tunnel" and does not see the slowdown gaining new momentum. Mizrahy noted that InMode introduced two new platforms, Ignite and Optimus Max, in 2024 but that this has not yet generated a new momentum. He also commented on the company's share buyback program, stating that the company invested $500 million in buybacks with "no results to the shareholders and to the company," and that the stock price was at $15 at the time of the call. Mizrahy added that InMode made a deliberate decision not to reduce its workforce during the slowdown. In earlier appearances, Mizrahy emphasized InMode's corporate culture and long-term strategy. In a January 2025 presentation, he described the company's "DNA" as including mutual respect, humility, compassion, integrity, and excellence, and said his commitment as CEO is to keep the company's stakeholders together as a "family." He stated that the company was established 17 years ago with the goal of being "build to last." During a 2022 conference, Mizrahy said that during the COVID-19 pandemic, he decided not to fire or let people go in order to retain talent, and that when the market reopened, InMode took market share from competitors. He has also stated that the company maintains a target of 85% gross margin on its products and that it will not acquire a laser company, as laser technology has become a commodity with lower margins.
“Although yes, we're making profit, we're a profitable company, the shareholders of this company have never taken one penny from day one. We never distributed dividend, profit sharing, nothing; all the money that we make every year goes back to the company for R&D, marketing, product development, territory development,...”
“We will never develop something that will not give your business a return on investment of less than one year. We will teach you how to do it with workshops, training, social media and everything that needs to be done by your clinic in order to make sure the return on investment on our platforms will pay off.”
“We made a deliberate decision as a company not to cut corners, not to reduce our workforce and to remain committed to leading the industry because we believe that when the market rebound and demand will return, we will be ready to lead and benefit as we have in the past following major challenges.”
“Earlier this month, we purchased 6.95 million shares totaling 127 million. In fact, over the past 12 months alone, we have returned more than $412 million to the shareholders through share purchase, representing approximately 27% of our total capital.”
Moshe Mizrahy, CEO of InMode, shares his perspective on the company’s vision, innovation roadmap, and the future of medical aesthetics. In this session, he discusses how InMode continues to lead through technology, clinical excellence, and practice-focused solutions.
04/28/2025 Q&A: 10:52 InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Moshe Mizrahy.